Results 221 to 230 of about 585,279 (298)
Checklist-Based Identification of Adverse Drug Reactions in Emergency Department Patients. [PDF]
Hellinger BJ +3 more
europepmc +1 more source
Tumbling Magnetic Microrobots for Targeted In Vivo Drug Delivery in the GI Tract
We introduce a microrobot design and integrated system for on‐demand targeted drug release in the gastrointestinal tract. The microrobot has an embedded magnet for actuation with external magnetic fields and is visualized in real time using ultrasound. It has two drug release ports sealed with a thermally sensitive wax. Local heating of the wax using a
Aaron C. Davis +7 more
wiley +1 more source
Cutaneous adverse drug reactions: A prospective observational study at a tertiary care hospital in Central India. [PDF]
Jain SK, Maurya PK, Singh B, Jain S.
europepmc +1 more source
Micro‐ and nanorobots for targeted thrombolysis. This perspective elaborates on the clinical indication of blood clot disorders and current limitations for treatment. As a novel, alternative solution, micro‐ and nanorobots can be used to treat and break down thrombi.
Joshua M. Mesfin +3 more
wiley +1 more source
Incidence and sex-related risk factors of linezolid-associated adverse drug reactions identified through electronic health records. [PDF]
Baek S, Oh J, Yoon S, Yoon S, Chung JY.
europepmc +1 more source
Our study identifies the HDACs‐STAT3 axis as key regulator for M2 macrophage accumulation in DLBCL. We developed Chid@M2pep‐EVs/TP, a pH‐responsive drug delivery system for M2 macrophage specific chidamide administration. By coupling M2‐targeted chidamide with EVs‐mediated delivery, this system reprograms M2 to M1 via HDAC inhibition and STAT3 ...
Bo Dai +15 more
wiley +1 more source
Association of Ticagrelor Metabolic SNPs With Adverse Drug Reactions in Patients With Acute Coronary Syndrome. [PDF]
Zhang Y +5 more
europepmc +1 more source
This study demonstrates that Mn2⁺–tumor DNA complexes encapsulated in dendritic cell (DC)– derived immunogenic extracellular vesicles (EVDC@Mn‐DNA) act as a DC‐specific cGAS– STING activator. EVDC@Mn‐DNA treatment enhances intratumoral DC activation, improves tumor vascular function, promotes CD8⁺ T cell activity, and suppresses pancreatic tumor growth,
Xue Jiang +13 more
wiley +1 more source
Association between HLA alleles and adverse drug reactions. Mechanisms involved. [PDF]
de Malet Pintos-Fonseca A +3 more
europepmc +1 more source
Comparison of two risk-screening tools for adverse drug reactions in older inpatients [PDF]
De Buyser, Stefanie +5 more
core +1 more source

